Ultrasound: Page 252

ABUS boosts mammography's performance
By Kate Madden Yee
Tuesday, November 27 | 3:30 p.m.-3:40 p.m. | SSJ01-04 | Arie Crown TheaterWhat does automated breast ultrasound (ABUS) contribute to cancer screening when it's used with mammography in women with dense breasts? Researchers from the University of Chicago will present findings that address this question on Tuesday afternoon.
November 13, 2012
US-guided core-needle breast biopsy OK for preop staging
By Kate Madden Yee
Tuesday, November 27 | 3:20 p.m.-3:30 p.m. | SSJ01-03 | Arie Crown TheaterWhich is better for assessing metastasis in newly diagnosed breast cancer: fine-needle aspiration or core biopsy? It's an important question, according to Finnish researchers, as the presence of axillary metastasis is the most significant prognostic factor in invasive breast cancer.
November 13, 2012
Triple-negative breast cancer shows specific US characteristics
By Kate Madden Yee
Tuesday, November 27 | 3:10 p.m.-3:20 p.m. | SSJ01-02 | Arie Crown TheaterCertain ultrasound characteristics can help clinicians identify triple-negative breast cancer, researchers from Chile will report in this scientific session.
November 13, 2012
ABUS detects suspicious lesions found on breast MRI
By Kate Madden Yee
Tuesday, November 27 | 3:00 p.m.-3:10 p.m. | SSJ01-01 | Arie Crown TheaterAutomated breast ultrasound (ABUS) could prove helpful for evaluating additional suspicious lesions identified by breast MRI, and it's faster and more cost-effective than handheld second-look ultrasound, according to a study that will be presented on Tuesday afternoon.
November 13, 2012
US matches MRI in identifying lesions seen on BSGI
By Kate Madden Yee
Monday, November 26 | 10:00 a.m.-10:10 a.m. | VSMI21-08 | Arie Crown TheaterMore than 50% of lesions seen on breast-specific gamma imaging (BSGI) can also be visualized with targeted ultrasound -- a percentage comparable to MRI results, according to researchers from George Washington University.
November 13, 2012
US, MRI tumor measurements can predict residual disease
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-BRS-SU5A | Lakeside Learning CenterHow best can doctors assess residual disease in inflammatory breast cancer patients who have undergone neoadjuvant chemotherapy? Find out in this Sunday poster presentation.
November 13, 2012
Annual breast US benefits women with dense tissue
By Kate Madden Yee
Sunday, November 25 | 11:25 a.m.-11:35 a.m. | SSA01-05 | Arie Crown TheaterSince the 2009 passage of the breast density notification law in Connecticut, radiologists have a legal obligation to inform patients with mammographically dense breast tissue that they may benefit from the addition of screening breast ultrasound. But how effective is that second round of screening?
November 13, 2012
ABUS plus mammography finds cancer early in women with dense tissue
By Kate Madden Yee
Sunday, November 25 | 11:05 a.m.-11:15 a.m. | SSA01-03 | Arie Crown TheaterScreening with automated breast ultrasound (ABUS) -- as an adjunct to digital mammography -- detects early-stage, node-negative invasive carcinoma in asymptomatic women with dense breast tissue, according to researchers from George Washington University Medical Center. And finding these cancers could reduce breast cancer mortality rates.
November 13, 2012
Screening US valuable for women with dense breast tissue
By Kate Madden Yee
Sunday, November 25 | 10:55 a.m.-11:05 a.m. | SSA01-02 | Arie Crown TheaterScreening ultrasound is a valuable tool for women with dense breast tissue, as errors in mammographic interpretation can be high -- up to 28% according to recent data, researchers from South Korea will report in this scientific session.
November 13, 2012
US alone compares well to mammography for cancer detection
By Kate Madden Yee
Sunday, November 25 | 10:45 a.m.-10:55 a.m. | SSA01-01 | Arie Crown TheaterCould ultrasound serve as the primary screening test for breast cancer? In this Sunday morning presentation, researchers from the University of Pittsburgh will discuss results from a study that used American College of Radiology Imaging Network (ACRIN) 6666 data to evaluate outcomes of screening if ultrasound were the primary screening modality.
November 13, 2012
Imorgon, TomTec form partnership
By AuntMinnie.com staff writers
Ultrasound image management firm Imorgon has entered into a strategic partnership with imaging software developer TomTec Imaging Systems to improve access to 3D imaging.
November 12, 2012
Cephasonics unveils new ultrasound API release
By AuntMinnie.com staff writers
Ultrasound technology and subsystems developer Cephasonics has introduced version 3.0 of its ultrasound application programming interface.
November 12, 2012
Previous Page
Page 252 of 521
Next Page